News
7h
MONTCO Today on MSNWSJ: GSK to Receive $370M in CureVac-BioNTech Vaccine Dispute
Glaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street Journal. The pharmaceutical powerhouse will ...
22h
TipRanks on MSNGSK Executives Acquire Shares Under Reward Plan
GSK plc announced the acquisition of ordinary shares by several key executives under the Company’s Share Reward Plan. This transaction, conducted on the London Stock Exchange, involved the purchase of ...
Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...
14d
GlobalData on MSNGSK’s speciality medicines soar while generals drop, Q2 results reveal
UK-based big pharma GlaxoSmithKline (GSK) has released its Q2 2025 results, which highlight the varying successes of its ...
After its own COVID-19 vaccine setback, GlaxoSmithKline has inked a $180 million deal to help German biotech company CureVac manufacture 100 million doses of its mRNA vaccine, which is currently ...
GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and inflammation.
Jan 15 (Reuters) - GlaxoSmithKline (GSK.L) on Saturday said it had rejected a 50-billion-pound offer from Unilever (ULVR.L) for its consumer goods arm, saying it "fundamentally undervalued" the ...
GlaxoSmithKline and CureVac have agreed to develop new vaccines that target multiple coronavirus variants. The shots, designed as boosters in case immunity from another vaccine drops, could be ...
LONDON—With its second-quarter report Wednesday, GlaxoSmithKline PLC GSK -1.52% has pivoted investors toward future expansion following its $20 billion asset swap with Novartis AG, saying it is ...
Avandia: GlaxoSmithKline Cover-Up Turns Off Doctors GlaxoSmithKline withheld studies that made their drug Avandia, look unsafe. By ABC News July 13, 2010, 11:24 AM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results